Navigation Links
Hard To Treat Diseases (HTDS.PK) Thailand Registration
Date:7/21/2009

SHENZHEN, China, July 21 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com announced today its intent to complete the registration of MEVAC-A for the country of Thailand. The registration is expected to be finished within the 3rd quarter of 2009.

This registration is required to accommodate a customer from Thailand, who has expressed interest in is Mellow Hope products such as MEVAC-A, MEVAC-DTaP, and MEVAC-ACYW.

Mellow Hope's Hepatitis A Vaccine is sold under the brand name MEVAC-A.

In total, the Company is in the process of registration, and clinical trials in countries of Southeast Asia, Latin America and Eastern Europe.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of Hard To Treat Diseases Inc that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. Hard To Treat Diseases Inc cautions you that any forward-looking information provided by or on behalf of Hard To Treat Diseases Inc is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard To Treat Diseases Inc's actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard To Treat Diseases Inc's control. In addition to those discussed in Hard To Treat Diseases Inc's press releases, public filings, and statements by Hard To Treat Diseases Inc's management, including, but not limited to, Hard To Treat Diseases Inc's estimate of the sufficiency of its existing capital resources, Hard To Treat Diseases Inc's ability to raise additional capital to fund future operations, Hard To Treat Diseases Inc's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard To Treat Diseases Inc's capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard To Treat Diseases Inc does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com; For any corporate matters, please contact corporate@htdsmedical.com, www.htdsmedical.com


'/>"/>
SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Fractional co2 Laser Offers Cosmetic Treatments with Minimal Downtime For Melbourne Patients
2. Earlier HIV antiviral treatment can be cost effective in areas of limited resources
3. New Alzheimers Treatment Could Be on the Horizon
4. New strategy in tumor treatment
5. Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop
6. Earlier HIV Treatment Could Save Lives Worldwide
7. For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors
8. -Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-
9. Lumenis UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars
10. Innovative Prostate Cancer Treatment Known as Sonablate(R) HIFU Now Available at Third Site in India
11. Addiction Treatment Will Help Make Health Reform Affordable, New Analysis Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Angeles, CA (PRWEB) , ... January 17, 2017 ... ... and concerned by the political/social/economic events, Dr. Carol Francis re-releases powerfully uplifting interview ... and magical moments that help everyone endure and pass through tough times, Dr. ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... music enthusiasts at the National Association of Music Merchants (NAMM) winter trade show, ... 22, 2017. , Etymotic’s ER•4® has long been the gold standard for high-definition, ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... accredited, online continuing education for EMS and firefighting professionals, has released four new ... Solution. These new courses are taught live in an online classroom and meet ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... announced its partnership with Sigfox in the U.S.A. to offer Internet ... including new offerings on large-scale environmental sensor deployments such as monitoring solutions ...
(Date:1/17/2017)... ... 2017 , ... Livionex, Inc., a Silicon Valley healthcare company focused on treating ... its dental gel that shows significant reduction in plaque levels and gum inflammation and ... was conducted at the Beckman Laser Institute at UC Irvine and has been published ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017  EMD Serono, the biopharmaceutical business ... in the U.S. and Canada , ... joined the company as Senior Vice President and Head ... Smith will oversee the Fertility and Endocrinology businesses in ... launched its first product last year with Gidget™, a ...
(Date:1/17/2017)... PARSIPPANY, N.J. , Jan. 17, 2017 Interpace ... that provides clinically useful molecular diagnostic tests and pathology ... it has received a letter dated January 13, 2017 ... it has regained compliance with the requirement of the ... price of $1.00 per share. The letter ...
(Date:1/17/2017)... , Jan. 17, 2017 Tempus, a ... care, and University Hospitals Seidman Cancer Center have ... making genomic data, advanced molecular analysis and clinical ... physicians and healthcare providers. As ... genomic and transcriptomic sequencing and analysis for ovarian ...
Breaking Medicine Technology: